Caris Life Sciences (CAI)
Health Care · Precision oncology and molecular diagnostics
Caris Life Sciences delivers precision oncology and molecular profiling solutions that help biopharma companies and physicians make treatment decisions through comprehensive tumor analysis.
What Caris Life Sciences does
Caris Life Sciences is a precision medicine company that provides molecular information and data analysis services focused on oncology. The company captures, aggregates, and analyzes molecular information from patient tumors to help biopharma partners and physicians improve therapeutic development, clinical program efficiency, and treatment selection. Its platform generates comprehensive molecular profiles that inform cancer treatment decisions and support drug development programs.
Themes: ["Precision oncology / molecular profiling","Cancer treatment personalization","Biopharma drug development support","Genomic data analytics","Molecular information services"]
Fundamentals
- Price$17.87 as of 2026-07-09 close
- Market cap$4.9B as of 2026-07-10
- 1-year return-34.1% as of 2026-07-09 close
- P/E144.08 as of 2026-07-10
- Net margin+3.8% as of 2026-07-10
- Gross margin+68.7% as of 2026-07-10
- ROE+6.5% as of 2026-07-10
- Debt / equity0.64 as of 2026-07-10
- Revenue growth (YoY)+78.8% as of 2026-07-10
- Revenue CAGR (3y)+62.9% SEC XBRL
- Beta0.31 as of 2026-07-10
Key risks (from latest filing)
["Significant competition from established oncology and molecular profiling companies and new market entrants; ability to compete and maintain market position is uncertain","Dependence on third-party payer reimbursement and coverage decisions; changes in reimbursement could materially impact financial performance","Material weakness in internal controls over financial reporting that requires remediation; regulatory compliance and FDA approval risks for solutions"]
Competitors & peers
- Foundation Medicine
- Guardant Health
- Invitae
- Myriad Genetics
- Tempus AI
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.